Market Cap ₹43 Cr.
Stock P/E
P/B 1.3
Current Price ₹29.5
Book Value ₹ 22.8
Face Value 10
52W High ₹36
Dividend Yield 0%
52W Low ₹ 18.3
Adeshwar Meditex Ltd manufactures and sells surgical wound dressing products and medical disposables. It offers sterile surgical wound dressing products, combidress/combipads, absorbent cotton gauzes, clinical bandages, plasters, antiseptics, and disinfectants, in addition to medical gloves and kits. The organisation was founded in 1951 and is centred in Mumbai, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 10 | 14 | 27 | 16 | 25 | 59 | 53 | 56 | 66 | 65 | 82 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | |
Total Income | 10 | 14 | 27 | 16 | 26 | 59 | 55 | 56 | 66 | 65 | 83 | |
Total Expenditure | 9 | 12 | 24 | 14 | 23 | 53 | 49 | 51 | 61 | 61 | 77 | |
Operating Profit | 1 | 2 | 3 | 2 | 2 | 6 | 6 | 6 | 5 | 4 | 6 | |
Interest | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | |
Profit Before Tax | 0 | 1 | 2 | 1 | 1 | 4 | 3 | 3 | 2 | 1 | 3 | |
Provision for Tax | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | |
Profit After Tax | 0 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 2 | 1 | 2 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 0 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 2 | 1 | 2 | |
Adjusted Earnings Per Share | 0 | 1.7 | 1.8 | 0.9 | 1.6 | 2.6 | 2.3 | 0 | 1.6 | 0.5 | 1.4 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 26% | 14% | 7% | 23% |
Operating Profit CAGR | 50% | 0% | 0% | 20% |
PAT CAGR | 100% | 0% | -8% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 40% | NA% | NA% | NA% |
ROE Average | 6% | 6% | 9% | 20% |
ROCE Average | 10% | 9% | 12% | 19% |
#(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 1 | 3 | 5 | 5 | 6 | 14 | 16 | 19 | 21 | 31 | 33 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 1 | 1 | 2 | 2 | 2 | 1 | 5 | 6 | 5 | 4 | 2 |
Other Non-Current Liabilities | -0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 9 | 8 | 7 | 7 | 7 | 18 | 22 | 29 | 36 | 37 | 31 |
Total Liabilities | 11 | 12 | 15 | 15 | 16 | 33 | 44 | 55 | 62 | 72 | 67 |
Fixed Assets | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 4 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 3 | 4 | 4 |
Total Current Assets | 8 | 9 | 11 | 12 | 13 | 29 | 39 | 50 | 57 | 65 | 60 |
Total Assets | 11 | 12 | 15 | 15 | 16 | 33 | 44 | 55 | 62 | 72 | 67 |
#(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 2 |
Cash Flow from Operating Activities | 0 | 0 | 0 | 0 | 0 | -1 | -6 | -1 | 3 | -2 | 6 |
Cash Flow from Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 2 | -1 | -1 | -1 |
Cash Flow from Financing Activities | 0 | 0 | 0 | 0 | 0 | 1 | 6 | -0 | -3 | 4 | -5 |
Net Cash Inflow / Outflow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | 1 | -0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 2 | 2 |
# | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0 | 1.67 | 1.84 | 0.86 | 1.55 | 2.57 | 2.26 | 0 | 1.59 | 0.55 | 1.44 |
CEPS(Rs) | 2.37 | 2.52 | 2.47 | 1.52 | 2.13 | 2.94 | 2.61 | 2.33 | 1.92 | 0.81 | 1.8 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 0 | 5.42 | 7.26 | 8.25 | 8.86 | 13.6 | 15.86 | 0 | 19.54 | 21.45 | 22.81 |
Core EBITDA Margin(%) | 8.18 | 10 | 8.76 | 11.17 | 7.49 | 9.42 | 7.33 | 9.77 | 7.14 | 5.24 | 6.34 |
EBIT Margin(%) | 4.69 | 9.75 | 7.84 | 9.23 | 7.23 | 8.96 | 10.11 | 9.67 | 7.02 | 5.01 | 6.06 |
Pre Tax Margin(%) | 4.69 | 8.26 | 6.54 | 5.84 | 4.98 | 6.12 | 5.9 | 5.18 | 3.55 | 1.84 | 3.53 |
PAT Margin (%) | 4.69 | 5.66 | 4.45 | 3.54 | 4.11 | 4.37 | 4.25 | 3.77 | 2.54 | 1.22 | 2.52 |
Cash Profit Margin (%) | 8.18 | 8.53 | 5.99 | 6.23 | 5.63 | 4.99 | 4.92 | 4.37 | 3.07 | 1.81 | 3.16 |
ROA(%) | 4.47 | 6.66 | 8.93 | 3.83 | 6.58 | 10.52 | 5.89 | 4.3 | 2.87 | 1.18 | 2.98 |
ROE(%) | 46.21 | 41.04 | 32.99 | 11.31 | 18.17 | 26.33 | 15.34 | 12.19 | 8.5 | 3.08 | 6.49 |
ROCE(%) | 19.91 | 32.84 | 29.48 | 15.72 | 16.75 | 28.76 | 17.59 | 14.29 | 11.13 | 6.98 | 10.06 |
Receivable days | 85.57 | 78.19 | 49.42 | 85.65 | 58.55 | 67.55 | 127.89 | 154.51 | 152.53 | 168.39 | 133.88 |
Inventory Days | 54.82 | 60.08 | 51.9 | 112.89 | 73.83 | 41.6 | 75.63 | 90.93 | 112.29 | 144.88 | 109.96 |
Payable days | 362.4 | 243.19 | 77.05 | 130.77 | 58.45 | 34.42 | 53.66 | 84.56 | 102.36 | 128.91 | 98.77 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.96 | 11.66 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.28 | 0.73 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.15 | 0.24 | 0.22 | 0.46 | 0.32 | 0.26 | 0.44 | 0.44 | 0.48 | 0.88 | 0.47 |
EV/Core EBITDA(x) | 1.79 | 1.92 | 2.36 | 3.87 | 3.65 | 2.71 | 4.13 | 4.32 | 6.41 | 15.64 | 7.01 |
Net Sales Growth(%) | 0 | 35.73 | 95.1 | -38.93 | 54.66 | 132.68 | -9.69 | 6.04 | 17.56 | -1.84 | 27.18 |
EBIT Growth(%) | 0 | 182.42 | 56.87 | -28.09 | 21.13 | 188.15 | 1.94 | 1.38 | -14.58 | -30.01 | 53.94 |
PAT Growth(%) | 0 | 63.75 | 53.64 | -51.49 | 79.81 | 147.24 | -12.1 | -6 | -20.73 | -52.73 | 161.52 |
EPS Growth(%) | 0 | 22.88 | 10.04 | -52.99 | 79.81 | 65.43 | -12.1 | 0 | -20.72 | -65.51 | 161.54 |
Debt/Equity(x) | 1.12 | 1.17 | 0.86 | 0.89 | 0.92 | 0.86 | 1.26 | 1.13 | 1.09 | 0.61 | 0.5 |
Current Ratio(x) | 0.95 | 1.14 | 1.55 | 1.86 | 1.79 | 1.61 | 1.76 | 1.71 | 1.59 | 1.76 | 1.9 |
Quick Ratio(x) | 0.75 | 0.78 | 0.89 | 1.05 | 1.13 | 1.14 | 1.16 | 1.22 | 0.86 | 1.07 | 1.12 |
Interest Cover(x) | 0 | 6.55 | 6.03 | 2.72 | 3.21 | 3.15 | 2.4 | 2.15 | 2.02 | 1.58 | 2.39 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.48 | 0.68 |
# | Mar 2013 | Sep 2013 | Sep 2014 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|
Promoter | 0 | 0 | 0 | 42.65 | 42.65 | 42.65 | 42.65 | 42.65 | 42.65 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 100 | 100 | 100 | 57.35 | 57.35 | 57.35 | 57.35 | 57.35 | 57.35 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Mar 2013 | Sep 2013 | Sep 2014 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|
Promoter | 0 | 0 | 0 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.2 | 0.2 | 0.28 | 0.83 | 0.83 | 0.83 | 0.83 | 0.83 | 0.83 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.2 | 0.2 | 0.28 | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About